Erysipelas

8 registered clinical trials studyying Erysipelas — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Comparing Short to Standard Amoxicillin Course for Erysipelas NCT07104552	Assistance Publique - Hôpitaux de Paris	Phase 4
Recruiting	Hospital at Home for Elderly Acute Ill Patients NCT05360914	Defactum, Central Denmark Region	N/A
Unknown	Musculoskeletal Ultrasound of the Ankles in Erysipelas-like Erythema of Familial Mediterranean Fever NCT03917277	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo NCT02902822	Centro Studi Gised	N/A
Terminated	Duration of ANtibiotic Therapy for CEllulitis NCT02032654	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Phase 4
Completed	A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study NCT01519778	Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 2
Terminated	Short Course of Amoxicillin for Erysipelas NCT01059123	Assistance Publique - Hôpitaux de Paris	Phase 4
Withdrawn	The Use of Oral Steroids in the Treatment of Cellulitis NCT00893048	Milton S. Hershey Medical Center	Phase 2